F313-0745 Screening compound: 2-[(diphenylcarbamoyl)methoxy]-N-[3-(trifluoromethyl)phenyl]acetamide

F313-0745 Screening compound: 2-[(diphenylcarbamoyl)methoxy]-N-[3-(trifluoromethyl)phenyl]acetamide
F313-0745 Screening compound: 2-[(diphenylcarbamoyl)methoxy]-N-[3-(trifluoromethyl)phenyl]acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound F313-0745
2-[(diphenylcarbamoyl)methoxy]-N-[3-(trifluoromethyl)phenyl]acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F313-0745

Molecular Formula

C23H19F3N2O3 (C23 H19 F3 N2 O3)

Compound Name

2-[(diphenylcarbamoyl)methoxy]-N-[3-(trifluoromethyl)phenyl]acetamide

IUPAC name

2-[(diphenylcarbamoyl)methoxy]-N-[3-(trifluoromethyl)phenyl]acetamide

SMILES

O=C(COCC(N(c1ccccc1)c1ccccc1)=O)Nc1cccc(C(F)(F)F)c1

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

428.41

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

4.267

Distribution Coefficient, logD

4.266

Water Solubility, LogSw

-4.42

Polar Surface Area

46.165

Acid Dissociation Constant (pKa)

10.37

Base Dissociation Constant (pKb)

-1.34

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

13.00

F313-0745 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

DGK Inhibitors Library (10558 compounds)

Protein Arginine Methyltransferases Library (27925 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Hemic and lymphatic
  • Skin
  • Metabolic
  • Immune system
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Metabolic
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Targets:
  • Kinases
  • Others
  • Proteases
Mechanism of action:
  • Epigenetic

References: we are preparing a list of scientific research reports with F313-0745 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F313-0745?
Check Price and Availability of F313-0745, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F313-0745 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F313-0745
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F313-0745
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F313-0745 available by request